Semin Liver Dis 2010; 30(4): 422-428
DOI: 10.1055/s-0030-1267542
DIAGNOSTIC PROBLEMS IN HEPATOLOGY

© Thieme Medical Publishers

Primary Hepatic Signet Ring Cell Neuroendocrine Tumor: A Case Report with Literature Review

Hongfa Zhu1 , Katherine Sun1 , Stephen C. Ward1 , Myron Schwartz2 , 3 , Swan N. Thung1 , 3 , Lihui Qin4
  • 1The Lillian and Henry M. Stratton-Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, New York
  • 2Department of Surgery, The Mount Sinai Medical Center, New York, New York
  • 3The Mount Sinai Liver Cancer Program, The Mount Sinai Medical Center, New York, New York
  • 4Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
Further Information

Publication History

Publication Date:
19 October 2010 (online)

ABSTRACT

Primary hepatic signet ring cell neuroendocrine tumor is extremely rare and is characterized by distinct intracytoplasmic hyaline vacuoles that are mucin negative and cytokeratin positive. The unique histological features may cause difficulty in diagnosis and delay patient care. Here the authors report a 49-year-old man with an incidental finding of a 2.7 cm liver mass in the absence of chronic liver disease. The resected tumor was grossly unencapsulated but well demarcated with friable tissue texture. Microscopically, the entire tumor consisted of sheets of monotonous cells separated by delicate microvasculature. The tumor cells had granular chromatin, inconspicuous nucleoli, and eosinophilic cytoplasm. Many of the tumor cells had eccentric, pale intracytoplasmic vacuoles resembling signet ring cells in adenocarcinoma. Immunohistochemical studies showed that the tumor cells were positive for neuroendocrine markers and that the intracytoplasmic vacuoles were negative for mucin but strongly positive for cytokeratins. Careful systemic search including OctreoScan scintigraphy (Mallinckrodt Medical, Inc., St. Louis, MO) and capsule endoscopy failed to reveal any other tumors. A diagnosis of primary hepatic signet ring cell neuroendocrine tumor was established. Ten months after surgery, the patient is well without any other detectable tumor on radiology. Serological neuroendocrine markers are also within normal limits.

REFERENCES

  • 1 Edmondson H A. Carcinoid tumor. In: Edmondson HA Tumors of the Liver and Intrahepatic Bile Ducts (Atlas of Tumor Pathology). Washington, DC; Armed Forces Institute of Pathology 1958: 105-111
  • 2 Iwao M, Nakamuta M, Enjoji M et al.. Primary hepatic carcinoid tumor: case report and review of 53 cases.  Med Sci Monit. 2001;  7(4) 746-750
  • 3 Nikfarjam M, Muralidharan V, Christophi C. Primary hepatic carcinoid tumours.  HPB (Oxford). 2004;  6(1) 13-17
  • 4 Fenoglio L M, Severini S, Ferrigno D et al.. Primary hepatic carcinoid: a case report and literature review.  World J Gastroenterol. 2009;  15(19) 2418-2422
  • 5 Papotti M, Galliano D, Monga G. Signet-ring cell carcinoid of the gallbladder.  Histopathology. 1990;  17(3) 255-259
  • 6 Butala R M, Moscovic E A. Neuroendocrine markers in pulmonary adenocarcinomas with signet-ring cells.  Hum Pathol. 1990;  21(10) 1082
  • 7 Stokes M B, Kumar A, Symmans W F, Scholes J V, Melamed J. Pancreatic endocrine tumor with signet ring cell features: a case report with novel ultrastructural observations.  Ultrastruct Pathol. 1998;  22(2) 147-152
  • 8 Perez-Montiel M D, Frankel W L, Suster S. Neuroendocrine carcinomas of the pancreas with ‘Rhabdoid’ features.  Am J Surg Pathol. 2003;  27(5) 642-649
  • 9 Chetty R, Asa S L. Pancreatic endocrine tumour with cytoplasmic keratin whorls. Is the term “rhabdoid” appropriate?.  J Clin Pathol. 2004;  57(10) 1106-1110
  • 10 Shia J, Erlandson R A, Klimstra D S. Whorls of intermediate filaments with entrapped neurosecretory granules correspond to the “rhabdoid” inclusions seen in pancreatic endocrine neoplasms.  Am J Surg Pathol. 2004;  28(2) 271-273
  • 11 Sioutos N, Virta S, Kessimian N. Primary hepatic carcinoid tumor. An electron microscopic and immunohistochemical study.  Am J Clin Pathol. 1991;  95(2) 172-175
  • 12 Aoki K, Sakamoto M, Mukai K, Kosuge T, Takayama T, Hiroshashi S. Signet-ring cell carcinoid: a primary hepatic carcinoid tumor with cytoplasmic inclusions comprising of aggregates of keratin.  Jpn J Clin Oncol. 1992;  22(1) 54-59
  • 13 Oh Y H, Kang G H, Kim O J. Primary hepatic carcinoid tumor with a paranuclear clear zone: a case report.  J Korean Med Sci. 1998;  13(3) 317-320
  • 14 Knox C D, Anderson C D, Lamps L W, Adkins R B, Pinson C W. Long-term survival after resection for primary hepatic carcinoid tumor.  Ann Surg Oncol. 2003;  10(10) 1171-1175
  • 15 Arista-Nasr J, Romero-Lagarza P, Pichardo-Bahena R. Artifactual signet-ring-like cells in endoscopic biopsy of gastric lymphoma.  Arch Pathol Lab Med. 1997;  121(6) 623-625
  • 16 Guillou L, Wadden C, Coindre J M, Krausz T, Fletcher C D. “Proximal-type” epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series.  Am J Surg Pathol. 1997;  21(2) 130-146
  • 17 Borek B T, McKee P H, Freeman J A, Maguire B, Brander W L, Calonje E. Primary malignant melanoma with rhabdoid features: a histologic and immunocytochemical study of three cases.  Am J Dermatopathol. 1998;  20(2) 123-127
  • 18 Tozbikian G, Shen R, Suster S. Signet ring cell gastric schwannoma: report of a new distinctive morphological variant.  Ann Diagn Pathol. 2008;  12(2) 146-152
  • 19 Matsukuma S, Aida S, Hata Y, Sugiura Y, Tamai S. Localized malignant peritoneal mesothelioma containing rhabdoid cells.  Pathol Int. 1996;  46(5) 389-391
  • 20 Dickersin G R, Young R H, Scully R E. Signet-ring stromal and related tumors of the ovary.  Ultrastruct Pathol. 1995;  19(5) 401-419
  • 21 Robrechts C, De Vos R, Van den Heuvel M et al.. Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour?.  Liver. 1998;  18(4) 288-293
  • 22 Komuta M, Spee B, Vander Borght S et al.. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.  Hepatology. 2008;  47(5) 1544-1556
  • 23 Yamaguchi R, Nakashima O, Ogata T, Hanada K, Kumabe T, Kojiro M. Hepatocellular carcinoma with an unusual neuroendocrine component.  Pathol Int. 2004;  54(11) 861-865
  • 24 Tang L H, Shia J, Soslow R A et al.. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix.  Am J Surg Pathol. 2008;  32(10) 1429-1443
  • 25 Hristov A C, Young R H, Vang R, Yemelyanova A V, Seidman J D, Ronnett B M. Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: a report of 30 cases.  Am J Surg Pathol. 2007;  31(10) 1502-1511
  • 26 Sasaki M, Nakanuma Y, Shimizu K, Izumi R. Pathological and immunohistochemical findings in a case of mucinous cholangiocarcinoma.  Pathol Int. 1995;  45(10) 781-786
  • 27 Serra S, Asa S L, Chetty R. Intracytoplasmic inclusions (including the so-called “rhabdoid” phenotype) in pancreatic endocrine tumors.  Endocr Pathol. 2006;  17(1) 75-81
  • 28 De Lott L B, Morrison C, Suster S, Cohn D E, Frankel W L. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites.  Arch Pathol Lab Med. 2005;  129(9) 1100-1105
  • 29 Jaffee I M, Rahmani M, Singhal M G, Younes M. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin.  Arch Pathol Lab Med. 2006;  130(10) 1522-1526

Lihui QinM.D. Ph.D. 

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College

525 East 68th St., New York, NY 10065

Email: liq9005@med.cornell.edu

    >